# Indaptus Therapeutics, Inc.: Form 8-K, filed Mar 13, 2024

- Company: [Indaptus Therapeutics, Inc.](/companies/indp.md) (CIK 1857044)
- Form: 8-K
- Filed: 2024-03-13
- Accepted by EDGAR: Mar 13, 2024, 08:00 ET
- Period: 2024-03-13
- Accession: 0001493152-24-009766
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1857044/000149315224009766/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1857044/000149315224009766/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1857044/000149315224009766/form8-k.htm

Filed Mar 13, 2024.
Source: SEC EDGAR, the filing index for accession 0001493152-24-009766. Last ingested by Listed: Nov 14, 2026, 21:10 ET. No prices; not investment advice.
